摘要 |
Compositions that include Toll-like Receptor 5 agonists and at least a portion of at least one papillomavirus protein, such as a papillomavirus suppressor binding protein, papillomavirus transforming protein and papillomavirus capsid protein, can be employed in methods that stimulate an immune response in a subject, in particular, a protective immune response in a subject. The Toll-like Receptor 5 agonist and papillomavirus protein can be components of a fusion protein, can be associated with at least one particle in a molar ratio no greater than about 1 and can be administered to subjects in relatively low doses. |
申请人 |
VAXINNATE CORPORATION;SHAW, ALAN, R.;SONG, LANGZHOU;TUSSEY, LYNDA, G. |
发明人 |
SHAW, ALAN, R.;SONG, LANGZHOU;TUSSEY, LYNDA, G. |